Latest filing published 21 Feb 2024 for KalVista Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas Andrew Crockett: trading record in brief
All filings by Thomas Andrew Crockett on record concern KalVista Pharmaceuticals, Inc., in the capacity of chief executive. In total, 58 filings cover trades dated from 21 November 2016 to 20 February 2024.
On the market, this insider has only sold: 44 sales, €4.8M in total. The rest of the record consists of 2 share grants and 7 option exercises. So far in 2024, the count stands at no purchases and 4 sales.
The record was last updated on 21 February 2024 with an open-market sale (€326k) in KalVista Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Andrew Crockett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 54,415 sharesCommon StockSEC:0001415889-24-004710:0
- 58,356 shares@ US$15.009334.0% of flowCommon StockSEC:0001415889-24-004120:0
- 122,500 sharesCommon StockSEC:0001415889-24-003475:0
- 9,300 shares@ US$16.17515.8% of flowCommon StockSEC:0001415889-24-002625:0
- 30,000 shares@ US$12.015113.6% of flowCommon StockSEC:0001209191-23-059907:0
- 33,583 sharesCommon StockSEC:0001209191-23-056267:0
- 8,000 shares0Common StockSEC:0001209191-23-054018:0
- 33,582 sharesCommon StockSEC:0001209191-23-046820:0
- 12,750 sharesCommon StockSEC:0001209191-23-031292:0
- 12,749 sharesCommon StockSEC:0001209191-23-012315:0
- 5,805 sharesCommon StockSEC:0001209191-22-058119:0
- 6,500 shares0Common StockSEC:0001209191-22-049030:0
- 5,805 sharesCommon StockSEC:0001209191-22-046855:0
- 10,000 shares@ US$17.06938.1% of flowCommon StockSEC:0001209191-22-018184:0
- 10,000 shares@ US$17.18417.7% of flowCommon StockSEC:0001209191-21-059042:0
- 4,350 shares@ US$23.87874.6% of flowCommon StockSEC:0001209191-21-045093:0
- 1,067 shares@ US$30.0381.4% of flowCommon StockSEC:0001209191-21-042450:0
- 8,933 shares@ US$30.054911.5% of flowCommon StockSEC:0001209191-21-040040:0
- 4,750 shares0Common StockSEC:0001209191-21-036588:0
19 of 19 declarations
